{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T14:10:31Z","timestamp":1778940631947,"version":"3.51.4"},"reference-count":42,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-23-CE17-0024-01"],"award-info":[{"award-number":["ANR-23-CE17-0024-01"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["PEPR THERA-B"],"award-info":[{"award-number":["PEPR THERA-B"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003032","name":"Association Nationale de la Recherche et de la Technologie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003032","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007525","name":"Universit\u00e9 de Rennes 1","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007525","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Oncology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.omton.2025.201104","type":"journal-article","created":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T23:44:03Z","timestamp":1763855043000},"page":"201104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Using the iCasp9 suicide strategy to control the growth and function of genome-edited B cells with redirected antigen specificity"],"prefix":"10.1016","volume":"33","author":[{"given":"Jenny","family":"L\u00e9onard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marine","family":"Cahen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Laure","family":"Tanguy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurent","family":"Deleurme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natsuko","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oph\u00e9lie","family":"D\u00e9z\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gr\u00e9gory","family":"No\u00ebl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maiwenn","family":"Pineau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe","family":"Ferrand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yannic","family":"Danger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Cogn\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.omton.2025.201104_bib1","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1158\/1078-0432.CCR-24-0071","article-title":"Chimeric Antigen Receptor T Cell with an Inducible Caspase 9 Suicide Gene Eradicates Uveal Melanoma Liver Metastases via B7-H3 Targeting","volume":"30","author":"Ventin","year":"2024","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.omton.2025.201104_bib2","first-page":"2","article-title":"Chimeric antigen receptor (CAR)-directed adoptive immunotherapy: a new era in targeted cancer therapy","volume":"1","author":"Chen","year":"2014","journal-title":"Stem Cell Investig."},{"key":"10.1016\/j.omton.2025.201104_bib3","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1056\/NEJMoa1504542","article-title":"Chimeric Antigen Receptor T Cells against CD19 for Multiple Myeloma","volume":"373","author":"Garfall","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omton.2025.201104_bib4","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1182\/blood-2008-09-177139","article-title":"Engineering human hematopoietic stem\/progenitor cells to produce a broadly neutralizing anti-HIV antibody after in vitro maturation to human B lymphocytes","volume":"113","author":"Luo","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.omton.2025.201104_bib5","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/s41419-020-03187-1","article-title":"Engineering of \u03b1-PD-1 antibody-expressing long-lived plasma cells by CRISPR\/Cas9-mediated targeted gene integration","volume":"11","author":"Luo","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.omton.2025.201104_bib6","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aax0644","article-title":"B cells engineered to express pathogen-specific antibodies protect against infection","volume":"4","author":"Moffett","year":"2019","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.omton.2025.201104_bib7","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.42995","article-title":"Reprogramming the antigen specificity of B cells using genome-editing technologies","volume":"8","author":"Voss","year":"2019","journal-title":"eLife"},{"key":"10.1016\/j.omton.2025.201104_bib8","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1182\/bloodadvances.2020003792","article-title":"Immunotherapy perspectives in the new era of B-cell editing","volume":"5","author":"Ueda","year":"2021","journal-title":"Blood Adv."},{"key":"10.1016\/j.omton.2025.201104_bib9","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-74005-3","article-title":"Single-hit genome editing optimized for maturation in B cells redirects their specificity toward tumor antigens","volume":"14","author":"Ueda","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omton.2025.201104_bib10","doi-asserted-by":"crossref","first-page":"4247","DOI":"10.1182\/blood-2004-11-4564","article-title":"An inducible caspase 9 safety switch for T-cell therapy","volume":"105","author":"Straathof","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.omton.2025.201104_bib11","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1056\/NEJMoa1106152","article-title":"Inducible Apoptosis as a Safety Switch for Adoptive Cell Therapy","volume":"365","author":"Di Stasi","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omton.2025.201104_bib12","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1158\/0008-5472.CAN-18-1078","article-title":"CML Hematopoietic Stem Cells Expressing IL1RAP Can Be Targeted by Chimeric Antigen Receptor-Engineered T Cells","volume":"79","author":"Warda","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.omton.2025.201104_bib13","doi-asserted-by":"crossref","first-page":"10437","DOI":"10.1073\/pnas.95.18.10437","article-title":"Redesigning an FKBP-ligand interface to generate chemical dimerizers with novel specificity","volume":"95","author":"Clackson","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omton.2025.201104_bib14","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.omtm.2021.03.002","article-title":"Improved safety of induced pluripotent stem cell-derived antigen-presenting cell-based cancer immunotherapy","volume":"21","author":"Mashima","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omton.2025.201104_bib15","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1177\/00912700122010771","article-title":"Intravenous safety and pharmacokinetics of a novel dimerizer drug, AP1903, in healthy volunteers","volume":"41","author":"Iuliucci","year":"2001","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.omton.2025.201104_bib16","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1182\/blood-2015-02-628354","article-title":"Inducible caspase-9 suicide gene controls adverse effects from alloreplete T cells after haploidentical stem cell transplantation","volume":"125","author":"Zhou","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.omton.2025.201104_bib17","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1158\/1078-0432.CCR-18-3069","article-title":"Phase I Trial of Inducible Caspase 9 T Cells in Adult Stem Cell Transplant Demonstrates Massive Clonotypic Proliferative Potential and Long-term Persistence of Transgenic T Cells","volume":"25","author":"Zhang","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.omton.2025.201104_bib18","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1038\/s41417-020-00284-3","article-title":"Overcoming target epitope masking resistance that can occur on low-antigen-expresser AML blasts after IL-1RAP chimeric antigen receptor T cell therapy using the inducible caspase 9 suicide gene safety switch","volume":"28","author":"Warda","year":"2021","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.omton.2025.201104_bib19","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.mucimm.2025.06.001","article-title":"Editing B cells at the IGHA2 gene position provides alternative route to therapeutic IgA production","volume":"18","author":"Cahen","year":"2025","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.omton.2025.201104_bib20","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.omtm.2022.05.011","article-title":"Targeted biallelic integration of an inducible Caspase 9 suicide gene in iPSCs for safer therapies. Molecular Therapy","volume":"26","author":"Wunderlich","year":"2022","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omton.2025.201104_bib21","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s10495-022-01774-5","article-title":"Escaping cell death via TRAIL decoy receptors: a systematic review of their roles and expressions in colorectal cancer","volume":"27","author":"Jong","year":"2022","journal-title":"Apoptosis"},{"key":"10.1016\/j.omton.2025.201104_bib22","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.immuni.2005.03.012","article-title":"Sustained survivin expression from OX40 costimulatory signals drives T cell clonal expansion","volume":"22","author":"Song","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.omton.2025.201104_bib23","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1002\/eji.200425818","article-title":"GITR: a multifaceted regulator of immunity belonging to the tumor necrosis factor receptor superfamily","volume":"35","author":"Nocentini","year":"2005","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.omton.2025.201104_bib24","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1126\/science.1209038","article-title":"The unfolded protein response: from stress pathway to homeostatic regulation","volume":"334","author":"Walter","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.omton.2025.201104_bib25","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1172\/JCI73448","article-title":"Inhibition of ER stress-associated IRE-1\/XBP-1 pathway reduces leukemic cell survival","volume":"124","author":"Tang","year":"2014","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.omton.2025.201104_bib26","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1182\/blood-2004-05-2006","article-title":"Pim-1 is up-regulated by constitutively activated FLT3 and plays a role in FLT3-mediated cell survival","volume":"105","author":"Kim","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.omton.2025.201104_bib27","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1182\/blood-2003-07-2469","article-title":"VavP-Bcl2 transgenic mice develop follicular lymphoma preceded by germinal center hyperplasia","volume":"103","author":"Egle","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.omton.2025.201104_bib28","doi-asserted-by":"crossref","first-page":"4213","DOI":"10.1182\/blood-2008-05-157255","article-title":"Overexpression of TOSO in CLL is triggered by B-cell receptor signaling and associated with progressive disease","volume":"112","author":"Pallasch","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.omton.2025.201104_bib29","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1038\/sj.onc.1207556","article-title":"Mitogen-activated protein kinases in apoptosis regulation","volume":"23","author":"Wada","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.omton.2025.201104_bib30","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/s41598-024-51259-5","article-title":"Selenoprotein P expression in glioblastoma as a regulator of ferroptosis sensitivity: preservation of GPX4 via the cycling-selenium storage","volume":"14","author":"Zheng","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omton.2025.201104_bib31","article-title":"IFIT3: a crucial mediator in innate immunity and tumor progression with therapeutic implications","volume":"16","author":"Wu","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omton.2025.201104_bib32","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1172\/JCI36666","article-title":"Amelioration of emphysema in mice through lentiviral transduction of long-lived pulmonary alveolar macrophages","volume":"120","author":"Wilson","year":"2010","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.omton.2025.201104_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.755639","article-title":"Inclusion of the Inducible Caspase 9 Suicide Gene in CAR Construct Increases Safety of CAR.CD19 T Cell Therapy in B-Cell Malignancies","volume":"12","author":"Guercio","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omton.2025.201104_bib34","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/gt.2016.39","article-title":"Exposure to hypomethylating agent, 5-azacytidine, may improve iCasp9 suicide gene therapy for treating GvHD in allografts","volume":"23","author":"B\u00f4le-Richard","year":"2016","journal-title":"Gene Ther."},{"key":"10.1016\/j.omton.2025.201104_bib35","doi-asserted-by":"crossref","DOI":"10.1038\/mtm.2014.53","article-title":"Development of an inducible caspase-9 safety switch for pluripotent stem cell-based therapies","volume":"1","author":"Wu","year":"2014","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omton.2025.201104_bib36","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.nephro.2015.07.144","article-title":"Lymphome de Burkit et atteinte r\u00e9nale, aspects th\u00e9rapeutiques et \u00e9volutifs","volume":"11","author":"Sadaoui","year":"2015","journal-title":"N\u00e9phrol. Th\u00e9rapeutique"},{"key":"10.1016\/j.omton.2025.201104_bib37","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nri.2016.62","article-title":"The unfolded protein response in immunity and inflammation","volume":"16","author":"Grootjans","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.omton.2025.201104_bib38","doi-asserted-by":"crossref","first-page":"6216","DOI":"10.1073\/pnas.94.12.6216","article-title":"A new member of the tumor necrosis factor\/nerve growth factor receptor family inhibits T cell receptor-induced apoptosis","volume":"94","author":"Nocentini","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omton.2025.201104_bib39","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1182\/blood.V99.12.4531","article-title":"Complementary functions of the antiapoptotic protein A1 and serine\/threonine kinase pim-1 in the BCR\/ABL-mediated leukemogenesis","volume":"99","author":"Nieborowska-Skorska","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.omton.2025.201104_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2024.102017","article-title":"HIST1H2BK predicts neoadjuvant-chemotherapy response and mediates 5-fluorouracil resistance of gastric cancer cells","volume":"46","author":"Chen","year":"2024","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.omton.2025.201104_bib41","doi-asserted-by":"crossref","first-page":"6365","DOI":"10.4049\/jimmunol.180.9.6365","article-title":"An inducible caspase 9 safety switch can halt cell therapy-induced autoimmune disease","volume":"180","author":"de Witte","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.omton.2025.201104_bib42","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41419-021-04468-z","article-title":"Cell-to-cell variability in inducible Caspase9-mediated cell death","volume":"13","author":"Yuan","year":"2022","journal-title":"Cell Death Dis."}],"container-title":["Molecular Therapy Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950329925001730?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950329925001730?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T13:37:36Z","timestamp":1778938656000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950329925001730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S2950329925001730"],"URL":"https:\/\/doi.org\/10.1016\/j.omton.2025.201104","relation":{},"ISSN":["2950-3299"],"issn-type":[{"value":"2950-3299","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Using the iCasp9 suicide strategy to control the growth and function of genome-edited B cells with redirected antigen specificity","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omton.2025.201104","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"201104"}}